HopeStage
Back to all studies
CompletedNCT00060489

Quetiapine for an acute depressive episode in bipolarity

About this titleRead the official source — NCT00060489
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Birmingham and 26 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2002
Recruitment status
Completed
Enrollment listed in the registry
Not clearly listed
Sponsor
AstraZeneca
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00060489
Official title
Show the full official title

Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham · Beverly Hills · La Mesa

24 more locations
  • San Diego
  • Jacksonville
  • Orlando
  • West Palm Beach
  • Winter Park
  • Atlanta
  • Smyrna
  • Oak Brook
  • Shreveport
  • Clementon
  • Moorestown
  • New York
  • Staten Island
  • Raleigh
  • Cincinnati
  • Cleveland
  • Dayton
  • Columbia
  • Memphis
  • Austin
  • Salt Lake City
  • Falls Church
  • Bellevue
  • Kirkland

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is AstraZeneca.

Did this study involve medication?

Yes. The study involved medication, including SEROQUEL (quetiapine fumarate) Tablets.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies